The Filing Desk

Avient vs Methanex

Avient AVNT · Methanex MEOH · Specialty Chemicals

Methanex reported revenue of $3.6 billion in fiscal 2025, about the same as Avient's $3.3 billion in fiscal 2025. Avient's revenue grew 0.6% in its latest year, and Methanex's fell 3.5%. Avient had an operating margin of 6.2%, against 12.0% at Methanex. Free cash flow was $195 million at Avient and $917 million at Methanex.

Side by side

AvientMethanex
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$3.3B$3.6B
Revenue growth0.6%−3.5%
Revenue growth a year, last 5 years8.0%6.3%
Gross margin31.1%35.7%
Operating margin6.2%12.0%
Net margin2.5%4.0%
Free cash flow$195M$917M
Free cash flow margin6.0%25.5%
Return on capital4.0%6.9%
Net debt to EBITDA3.6x2.6x
Dividends and buybacks$99M$54M
Change in diluted share count−0.2%7.5%
Last close$43.33$63.08
P/E at the last close22.2×—
Insider trades, last 12 months——
Piotroski F-score6 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
AvientMethanex
Operating margin
Percent of revenue
AvientMethanex
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AvientMethanex

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Avient and Methanex pages.